These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 33482855)

  • 21. Relapsing-remitting clinical course expands the phenotype of Aicardi-Goutières syndrome.
    Lambe J; Murphy OC; Mu W; Sondergaard Schatz K; Barañano KW; Venkatesan A
    Ann Clin Transl Neurol; 2020 Feb; 7(2):254-258. PubMed ID: 31920009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel RNASEH2B splice site mutation responsible for Aicardi-Goutieres syndrome in the Faroe Islands.
    Ostergaard E; Joensen F; Sundberg K; Duno M; Hansen FJ; Batbayli M; Sørensen N; Born AP
    Acta Paediatr; 2012 Nov; 101(11):e509-13. PubMed ID: 22882256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination of exome sequencing and immune testing confirms Aicardi-Goutières syndrome type 5 in a challenging pediatric neurology case.
    Haskell GT; Mori M; Powell C; Amrhein TJ; Rice GI; Bailey L; Strande N; Weck KE; Evans JP; Berg JS; Kishnani P
    Cold Spring Harb Mol Case Stud; 2018 Oct; 4(5):. PubMed ID: 30275001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Striking intrafamilial phenotypic variability in Aicardi-Goutières syndrome associated with the recurrent Asian founder mutation in RNASEH2C.
    Vogt J; Agrawal S; Ibrahim Z; Southwood TR; Philip S; Macpherson L; Bhole MV; Crow YJ; Oley C
    Am J Med Genet A; 2013 Feb; 161A(2):338-42. PubMed ID: 23322642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Late diagnosis and atypical brain imaging of Aicardi-Goutières syndrome: are we failing to diagnose Aicardi-Goutières syndrome-2?
    Svingen L; Goheen M; Godfrey R; Wahl C; Baker EH; Gahl WA; Malicdan MCV; Toro C
    Dev Med Child Neurol; 2017 Dec; 59(12):1307-1311. PubMed ID: 28762473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p.Arg69Trp in RNASEH2C is a founder variant in three Indian families with Aicardi-Goutières syndrome.
    Hebbar M; Kanthi A; Shrikiran A; Patil S; Muranjan M; Francis F; Bhat B V; Girisha KM; Shukla A
    Am J Med Genet A; 2018 Jan; 176(1):156-160. PubMed ID: 29150899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Astrocytes, an active player in Aicardi-Goutières syndrome.
    Sase S; Takanohashi A; Vanderver A; Almad A
    Brain Pathol; 2018 May; 28(3):399-407. PubMed ID: 29740948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expanding the phenotypic spectrum of lupus erythematosus in Aicardi-Goutières syndrome.
    Ramantani G; Kohlhase J; Hertzberg C; Innes AM; Engel K; Hunger S; Borozdin W; Mah JK; Ungerath K; Walkenhorst H; Richardt HH; Buckard J; Bevot A; Siegel C; von Stülpnagel C; Ikonomidou C; Thomas K; Proud V; Niemann F; Wieczorek D; Häusler M; Niggemann P; Baltaci V; Conrad K; Lebon P; Lee-Kirsch MA
    Arthritis Rheum; 2010 May; 62(5):1469-77. PubMed ID: 20131292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon-Stimulated Gene Expression as a Preferred Biomarker for Disease Activity in Aicardi-Goutières Syndrome.
    Wang BX; Grover SA; Kannu P; Yoon G; Laxer RM; Yeh EA; Fish EN
    J Interferon Cytokine Res; 2017 Apr; 37(4):147-152. PubMed ID: 28387595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A nationwide survey of Aicardi-Goutières syndrome patients identifies a strong association between dominant TREX1 mutations and chilblain lesions: Japanese cohort study.
    Abe J; Nakamura K; Nishikomori R; Kato M; Mitsuiki N; Izawa K; Awaya T; Kawai T; Yasumi T; Toyoshima I; Hasegawa K; Ohshima Y; Hiragi T; Sasahara Y; Suzuki Y; Kikuchi M; Osaka H; Ohya T; Ninomiya S; Fujikawa S; Akasaka M; Iwata N; Kawakita A; Funatsuka M; Shintaku H; Ohara O; Ichinose H; Heike T
    Rheumatology (Oxford); 2014 Mar; 53(3):448-58. PubMed ID: 24300241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aicardi-Goutières syndrome: unusual neuro-radiological manifestations.
    Abdel-Salam GMH; Abdel-Hamid MS; Mohammad SA; Abdel-Ghafar SF; Soliman DR; El-Bassyouni HT; Effat L; Zaki MS
    Metab Brain Dis; 2017 Jun; 32(3):679-683. PubMed ID: 28332073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical and genetic analysis of a family with Aicardi-Goutières syndrome and literature review].
    Ji T; Wang J; Li H; Zhao L; Sang Y; Wu Y
    Zhonghua Er Ke Za Zhi; 2014 Nov; 52(11):822-7. PubMed ID: 25582466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular Genetics and Interferon Signature in the Italian Aicardi Goutières Syndrome Cohort: Report of 12 New Cases and Literature Review.
    Garau J; Cavallera V; Valente M; Tonduti D; Sproviero D; Zucca S; Battaglia D; Battini R; Bertini E; Cappanera S; Chiapparini L; Crasà C; Crichiutti G; Dalla Giustina E; D'Arrigo S; De Giorgis V; De Simone M; Galli J; La Piana R; Messana T; Moroni I; Nardocci N; Panteghini C; Parazzini C; Pichiecchio A; Pini A; Ricci F; Saletti V; Salvatici E; Santorelli FM; Sartori S; Tinelli F; Uggetti C; Veneselli E; Zorzi G; Garavaglia B; Fazzi E; Orcesi S; Cereda C
    J Clin Med; 2019 May; 8(5):. PubMed ID: 31130681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rare ADAR and RNASEH2B variants and a type I interferon signature in glioma and prostate carcinoma risk and tumorigenesis.
    Beyer U; Brand F; Martens H; Weder J; Christians A; Elyan N; Hentschel B; Westphal M; Schackert G; Pietsch T; Hong B; Krauss JK; Samii A; Raab P; Das A; Dumitru CA; Sandalcioglu IE; Hakenberg OW; Erbersdobler A; Lehmann U; Reifenberger G; Weller M; Reijns MAM; Preller M; Wiese B; Hartmann C; Weber RG
    Acta Neuropathol; 2017 Dec; 134(6):905-922. PubMed ID: 29030706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Aicardi-Goutieres syndrome: a family case due to alteration of the RNASEH2B gene].
    Viguera-Elías D; de la Iglesia-Nagore I; Toledo-Gotor C; Domínguez-Garrido E; Poch-Olivé ML
    Rev Neurol; 2021 Jun; 72(11):407-409. PubMed ID: 34042169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aicardi-Goutières syndrome-associated mutation at ADAR1 gene locus activates innate immune response in mouse brain.
    Guo X; Wiley CA; Steinman RA; Sheng Y; Ji B; Wang J; Zhang L; Wang T; Zenatai M; Billiar TR; Wang Q
    J Neuroinflammation; 2021 Jul; 18(1):169. PubMed ID: 34332594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neonatal detection of Aicardi Goutières Syndrome by increased C26:0 lysophosphatidylcholine and interferon signature on newborn screening blood spots.
    Armangue T; Orsini JJ; Takanohashi A; Gavazzi F; Conant A; Ulrick N; Morrissey MA; Nahhas N; Helman G; Gordish-Dressman H; Orcesi S; Tonduti D; Stutterd C; van Haren K; Toro C; Iglesias AD; van der Knaap MS; Goldbach Mansky R; Moser AB; Jones RO; Vanderver A
    Mol Genet Metab; 2017 Nov; 122(3):134-139. PubMed ID: 28739201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and neuroradiologic variability of Aicardi-Goutiéres syndrome: Two siblings with RNASEH2C mutation and a boy with TREX1 mutation.
    Uyur Yalçın E; Maraş Genç H; Kara B
    Turk J Pediatr; 2015; 57(5):504-8. PubMed ID: 27411419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Developmental Outcomes of Aicardi Goutières Syndrome.
    Adang L; Gavazzi F; De Simone M; Fazzi E; Galli J; Koh J; Kramer-Golinkoff J; De Giorgis V; Orcesi S; Peer K; Ulrick N; Woidill S; Shults J; Vanderver A
    J Child Neurol; 2020 Jan; 35(1):7-16. PubMed ID: 31559893
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.